ClinicalTrials.Veeva

Menu

Better Life by Nutrition During Adulthood (BELINDA)

U

University Hospital, Lille

Status

Completed

Conditions

Cardiovascular Risk Factor

Study type

Observational

Funder types

Other

Identifiers

NCT02899416
2015_24
2016-A00386-45 (Other Identifier)

Details and patient eligibility

About

BELINDA is a follow'up of subjects included 10 years ago in HELENA study which was a cross-sectional study carried out from 2006 to 2007 in more than 3500 adolescents aged from 12.5 to 17.5 years old through 10 Europeans towns from 9 countries.

BELINDA main objective is to assess CV risk using PDAY score (Pathobiological Determinants of Atherosclerosis in Youth) during young adulthood (20 to 31 years) and analyze lifestyle risk factors from adolescence (12 to 18 years). This analyze may define new CV risk factors and risk population cluster.

Full description

BELINDA subjects from Lille, Ghent , Zaragoza and Roma will be re-tested using a part of HELENA test battery and some new evaluation criteria.

Enrollment

72 patients

Sex

All

Ages

20 to 35 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Women of men participating to HELENA study 2006-2007
  • Aged from 20 to 35 years.
  • Signed informed consent

Exclusion criteria

  • Pregnant or lactating women

Trial contacts and locations

1

Loading...

Central trial contact

Frédéric Gottrand, MD,PhD; Laurent Beghin, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems